文献速递牙周病

牙周炎患者可溶性CD163水平升高

Increased levels of soluble CD163 in periodontitis patients.
PubMed 文献 · J Clin Periodontol · 2017-05-16

这项横断面研究检测了70例牙周炎患者和70例牙周健康者的血清可溶性CD163水平,并在一部分人群中检测唾液,另从20例牙周炎患者取牙龈活检比较CD163 mRNA表达。结果显示牙周炎患者血清和唾液可溶性CD163均显著升高,且病变部位CD163基因表达显著上调。

要点

  • 牙周炎患者血清可溶性CD163显著高于牙周健康者。
  • 牙周炎患者唾液可溶性CD163显著高于牙周健康者,且与血清水平正相关。
  • 牙周炎患者病变牙龈部位CD163基因表达显著高于非病变部位。

核心结论

  • 研究提示CD163可能参与牙周炎的发病机制及其与全身状况的联系。

研究设计与样本

  • 横断面研究,纳入70例牙周炎患者和70例牙周健康者检测血清可溶性CD163,并在部分人群中检测唾液。
  • 从20例牙周炎患者每人取两份牙龈活检,一份来自牙周病变部位,另一份来自健康部位,用实时PCR评估CD163 mRNA相对表达。

主要发现

  • 血清可溶性CD163在牙周炎患者为720.0 ± 330.6 ng/ml,高于牙周健康者的510.7 ± 219.6 ng/ml(p < .001)。
  • 唾液可溶性CD163在牙周炎患者为3.01 ± 5.07 ng/ml,高于牙周健康者的1.98 ± 4.95 ng/ml(p = .009)。
  • 血清与唾液可溶性CD163水平呈正相关(Kendall's tau .27,p = .018)。
  • 牙周炎患者病变部位的CD163基因表达显著高于非病变部位,平均上调倍数为9.9(STD:15.3,p = .010)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Soluble CD163 (sCD163) has been implicated as a new biomarker in inflammatory conditions. The aim of this cross-sectional study was to assess CD163 levels systemically and locally in patients with chronic periodontitis. METHODS: sCD163 levels were measured by ELISA in serum samples from 70 periodontitis and 70 periodontally healthy subjects, and in saliva samples in a subset of the population. Two gingival biopsies were harvested per subject from 20 periodontitis patients: one from a periodontally affected site, the other from a healthy site, and the relative expression of CD163 mRNA was assessed by real-time PCR. RESULTS: Serum sCD163 was significantly higher in periodontitis patients compared to periodontally healthy subjects (720.0 ± 330.6 ng/ml versus 510.7 ± 219.6 ng/ml, respectively; p < .001). Similarly, sCD163 levels in saliva were significantly increased in periodontitis compared to healthy subjects (3.01 ± 5.07 ng/ml versus 1.98 ± 4.95 ng/ml, respectively; p = .009). Serum and saliva sCD163 levels showed a positive correlation (Kendall's tau .27, p = .018). Importantly, CD163 gene expression was significantly higher in affected sites compared to unaffected sites in periodontitis patients, with a mean fold upregulation of 9.9 (STD: 15.3, p = .010). CONCLUSION: Our findings suggest that CD163 may be involved in the pathogenesis of periodontitis and its link with systemic conditions.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Detzen L, Chen SCY, Cheng B, et al. Increased levels of soluble CD163 in periodontitis patients. J Clin Periodontol. 2017. PMID: 28419494. doi:10.1111/jcpe.12731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。